AI predicts frailty risk in adult congenital heart disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This study uses artificial intelligence (computer programs) to predict frailty risk—the chance of becoming weak or less able to do daily activities—in adults with congenital heart disease. It may help find early signs of frailty so doctors can offer support sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years old or older.
- A doctor has told you that you have congenital heart disease (a heart problem present at birth).
- You can speak Mandarin or Taiwanese well enough to answer questions.
- You do not have other birth defects or genetic conditions.
- You are not currently hospitalized for sudden heart symptoms, and you do not have severe memory or thinking issues.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI-powered chat system that offers social support to older adults with chronic heart failure. It may help you feel more supported and manage your condition better.
This study uses artificial intelligence to predict how well your heart is pumping by looking at your heart ultrasound results and body composition (like body fat and muscle). The goal is to see if adding body composition data makes the AI predictions more accurate.
This study uses an AI tool to look at your ECG (a simple heart test) to help find early signs of atrial fibrillation (an irregular heartbeat) or structural heart disease (changes in heart structure). It aims to see if the AI can help doctors catch these conditions sooner, even in people who don't yet have symptoms.
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
This study uses artificial intelligence to analyze heart tests (ECGs) to help diagnose and predict outcomes for people with heart disease. It may lead to better and faster detection of heart conditions.
This study uses artificial intelligence to help evaluate heart ultrasounds. It is testing whether AI can accurately measure heart function in adults with various heart conditions, such as coronary disease, valve problems, high blood pressure, atrial fibrillation, heart failure, or cardiomyopathy.
Hear when a new Adult Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.